210 related articles for article (PubMed ID: 2416370)
41. Discrepancies between antibody (EIA) and saturation analysis of oestrogen receptor content in breast tumour samples.
Marsigliante S; Puddefoot JR; Barker S; Gledhill J; Vinson GP
J Steroid Biochem Mol Biol; 1990 Dec; 37(5):643-8. PubMed ID: 2278849
[TBL] [Abstract][Full Text] [Related]
42. Detection of estrophilin in frozen sections of breast cancers using an estrogen receptor immunocytochemical assay.
Ozzello L; De Rosa CM; Konrath JG; Yeager JL; Miller LS
Cancer Res; 1986 Aug; 46(8 Suppl):4303s-4307s. PubMed ID: 2425948
[TBL] [Abstract][Full Text] [Related]
43. [Immunocytochemical assay of estrogen receptors in puncture products of breast carcinomas].
Faverly D; Querton G; Degeyter M; Lenglet G; Devleeschouwer N; Leclercq G
Bull Cancer; 1990; 77(7):667-74. PubMed ID: 2207355
[TBL] [Abstract][Full Text] [Related]
44. Immunoperoxidase localization of estrogen receptors in human brest carcinoma.
Garancis JC; Miller LS; Tomita JT; Tieu TM; Clowry LJ
Cancer Detect Prev; 1983; 6(1-2):235-9. PubMed ID: 6192919
[TBL] [Abstract][Full Text] [Related]
45. Quantitative immunological detection of estrogen receptors in nuclear pellets from human breast cancer biopsies.
Thorpe SM; Lykkesfeldt AE; Vinterby A; Lonsdorfer M
Cancer Res; 1986 Aug; 46(8 Suppl):4251s-4255s. PubMed ID: 3015386
[TBL] [Abstract][Full Text] [Related]
46. Estimation of PR and ER by immunocytochemistry in breast cancer. Comparison with radioligand binding methods.
Seymour L; Meyer K; Esser J; MacPhail AP; Behr A; Bezwoda WR
Am J Clin Pathol; 1990 Oct; 94(4 Suppl 1):S35-40. PubMed ID: 1699410
[TBL] [Abstract][Full Text] [Related]
47. [Immunohistochemical determination of estrogen receptors in breast carcinoma tissue using monoclonal antibodies. 1st clinical findings].
Jonat W; Stegner HE; Maass H
Geburtshilfe Frauenheilkd; 1985 Jul; 45(7):473-6. PubMed ID: 3896915
[TBL] [Abstract][Full Text] [Related]
48. Multiparametric study (SAMBA 200) of estrogen receptor immunocytochemical assay in 400 human breast carcinomas: analysis of estrogen receptor distribution heterogeneity in tissues and correlations with dextran coated charcoal assays and morphological data.
Charpin C; Martin PM; De Victor B; Lavaut MN; Habib MC; Andrac L; Toga M
Cancer Res; 1988 Mar; 48(6):1578-86. PubMed ID: 2449956
[TBL] [Abstract][Full Text] [Related]
49. Use of an enzymeimmunoassay (EIA) for quantitation of cytosolic and nuclear estrogen receptor, and correlation with progesterone receptor in human breast cancer.
Mobbs BG; Johnson IE
J Steroid Biochem; 1987 Dec; 28(6):653-62. PubMed ID: 3320574
[TBL] [Abstract][Full Text] [Related]
50. A comparison of two steroid receptor assays in breast cancer: dextran coated charcoal and isoelectric focusing.
Fernö M; Borg A; Norgren A
Anticancer Res; 1983; 3(4):243-6. PubMed ID: 6192752
[TBL] [Abstract][Full Text] [Related]
51. Use of monoclonal antibody for assessment of estrogen receptor content in fine-needle aspiration biopsy specimen from patients with breast cancer.
Masood S
Arch Pathol Lab Med; 1989 Jan; 113(1):26-30. PubMed ID: 2462858
[TBL] [Abstract][Full Text] [Related]
52. Estrogen receptor determination in endometrial carcinoma: ligand binding assay versus enzyme immunoassay.
Nyholm HC; Nielsen AL; Lyndrup J; Greene GL; Thorpe SM
Anticancer Res; 1995; 15(2):649-54. PubMed ID: 7763051
[TBL] [Abstract][Full Text] [Related]
53. Cytologic diagnosis of estrogen and progesterone receptors in breast imprints.
Sasaki M; Morimoto K; Koh M; Wakasa K; Haba T; Kinoshita H
Acta Cytol; 2002; 46(6):1056-60. PubMed ID: 12462082
[TBL] [Abstract][Full Text] [Related]
54. [Clinical and methodological considerations in the quantification of estrogen and progesterone receptors using monoclonal antibodies in breast cancer].
Navarro MA; Huguet J; Valero J; Samaniego JM; Rosel P; Sirvent JJ
Med Clin (Barc); 1991 Jun; 97(2):41-4. PubMed ID: 1895780
[TBL] [Abstract][Full Text] [Related]
55. Measurement of estrogen and progesterone receptors in human breast tumors: enzyme immunoassay versus binding assay.
Holmes FA; Fritsche HA; Loewy JW; Geitner AM; Sutton RC; Buzdar AU; Hortobagyi GN
J Clin Oncol; 1990 Jun; 8(6):1025-35. PubMed ID: 2189952
[TBL] [Abstract][Full Text] [Related]
56. Comparison of an immunocytochemical assay for progesterone receptor with a biochemical method of measurement and immunocytochemical examination of the relationship between progesterone and estrogen receptors.
Berger U; Wilson P; Thethi S; McClelland RA; Greene GL; Coombes RC
Cancer Res; 1989 Sep; 49(18):5176-9. PubMed ID: 2766287
[TBL] [Abstract][Full Text] [Related]
57. Estrogen receptors in human breast cancer: comparative features of the hydroxylapatite- and dextran-coated charcoal assay.
Poulsen HS
Eur J Cancer Clin Oncol; 1982 Nov; 18(11):1075-9. PubMed ID: 6186496
[TBL] [Abstract][Full Text] [Related]
58. Determination of estrogen and progesterone receptors in human breast cancer cytosols: a comparison between radioligand binding assay (DCC) and enzyme immunoassay (EIA).
Cerra M; Cecco L; Montella M; Celentano E; Bonelli P; Tuccillo F
Int J Biol Markers; 1996; 11(1):50-2. PubMed ID: 8740643
[No Abstract] [Full Text] [Related]
59. Steroid receptor assays: an Italian quality assessment program.
Piffanelli A; Giovannini G; Pelizzola D; De Bortoli M; Catozzi L; Giganti M
Ann Ist Super Sanita; 1991; 27(3):523-9. PubMed ID: 1809075
[TBL] [Abstract][Full Text] [Related]
60. [Detection of estrogen receptor (ER) mRNA by use of reverse transcriptase-polymerase chain reaction (RT-PCR) assay; comparison with dextran coated charcoal (DCC) assay and immunocytochemical assay].
Ozaki T
Gan To Kagaku Ryoho; 1992 Mar; 19(3):361-6. PubMed ID: 1371912
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
